{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:37:35Z","timestamp":1795030655984,"version":"4.10.2"},"reference-count":92,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2020,2,3]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>The pathophysiological background of decompensated cirrhosis is characterised by a systemic proinflammatory and pro-oxidant milieu that plays a major role in the development of multiorgan dysfunction. Such abnormality is mainly due to the systemic spread of bacteria and\/or bacterial products from the gut and danger-associated molecular patterns from the diseased liver triggering the release of proinflammatory mediators by activating immune cells. The exacerbation of these processes underlies the development of acute-on-chronic liver failure. A further mechanism promoting multiorgan dysfunction and failure likely consists with a mitochondrial oxidative phosphorylation dysfunction responsible for systemic cellular energy crisis. The systemic proinflammatory and pro-oxidant state of patients with decompensated cirrhosis is also responsible for structural and functional changes in the albumin molecule, which spoil its pleiotropic non-oncotic properties such as antioxidant, scavenging, immune-modulating and endothelium protective functions. The knowledge of these abnormalities provides novel targets for mechanistic treatments. In this respect, the oncotic and non-oncotic properties of albumin make it a potential multitarget agent. This would expand the well-established indications to the use of albumin in decompensated cirrhosis, which mainly aim at improving effective volaemia or preventing its deterioration. Evidence has been recently provided that long-term albumin administration to patients with cirrhosis and ascites improves survival, prevents complications, eases the management of ascites and reduces hospitalisations. However, variant results indicate that further investigations are needed, aiming at confirming the beneficial effects of albumin, clarifying its optimal dosage and administration schedule and identify patients who would benefit most from long-term albumin administration.<\/jats:p>","DOI":"10.1136\/gutjnl-2019-318843","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T17:25:17Z","timestamp":1582737917000},"page":"1127-1138","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":332,"title":["Albumin in decompensated cirrhosis: new concepts and perspectives"],"prefix":"10.1136","volume":"69","clinical-trial-number":[{"clinical-trial-number":"nct03451292","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03065699","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03702920","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-5440","authenticated-orcid":false,"given":"Mauro","family":"Bernardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1913-0716","authenticated-orcid":false,"given":"Paolo","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4333-7749","authenticated-orcid":false,"given":"Joan","family":"Claria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L","family":"Gerbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair J","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Thevenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"2024111100501115000_69.6.1127.1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis \u2013 a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"2024111100501115000_69.6.1127.2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2468-1253(16)30081-4","article-title":"Screening for liver fibrosis in the general population: a call for action","volume":"1","author":"Gin\u00e8s","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024111100501115000_69.6.1127.3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gin\u00e9s","year":"1987","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2024111100501115000_69.6.1127.6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hern\u00e1ez","year":"2017","journal-title":"Gut"},{"key":"2024111100501115000_69.6.1127.8","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2024111100501115000_69.6.1127.9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med Overseas Ed"},{"key":"2024111100501115000_69.6.1127.11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"M\u00f8ller","year":"2018","journal-title":"Liver Int"},{"key":"2024111100501115000_69.6.1127.12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"key":"2024111100501115000_69.6.1127.13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","article-title":"Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome","volume":"46","author":"Arroyo","year":"2007","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.14","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2010.08.001","article-title":"Renal and circulatory dysfunction in cirrhosis: current management and future perspectives","volume":"53","author":"Sol\u00e0","year":"2010","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jhep.2017.01.011","article-title":"Diagnosis and treatment of ascites","volume":"67","author":"Tsochatzis","year":"2017","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000444553","article-title":"Liver cirrhosis and kidney","volume":"34","author":"Gerbes","year":"2016","journal-title":"Dig Dis"},{"key":"2024111100501115000_69.6.1127.17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.18","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"2024111100501115000_69.6.1127.19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"key":"2024111100501115000_69.6.1127.20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.23","doi-asserted-by":"crossref","DOI":"10.1038\/srep32341","article-title":"Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis","volume":"6","author":"Sol\u00e9","year":"2016","journal-title":"Sci Rep"},{"key":"2024111100501115000_69.6.1127.24","first-page":"36","article-title":"Albumin administration in sepsis: the case for and against","volume":"17","author":"Glassford","year":"2017","journal-title":"ICU Manag Pract"},{"key":"2024111100501115000_69.6.1127.25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"2024111100501115000_69.6.1127.26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/gutjnl-2018-316227","article-title":"Circulating microbiome in blood of different circulatory compartments","volume":"68","author":"Schierwagen","year":"2019","journal-title":"Gut"},{"key":"2024111100501115000_69.6.1127.27","doi-asserted-by":"crossref","unstructured":"Queck A , Carnevale R , Uschner FE , et al . Role of portal venous platelet activation in patients with decompensated cirrhosis and tips. Gut 2019. doi:doi:10.1136\/gutjnl-2019-319044. [Epub ahead of print: 3 Jul 2019].","DOI":"10.1136\/gutjnl-2019-319044"},{"key":"2024111100501115000_69.6.1127.28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fern\u00e1ndez","year":"2019","journal-title":"Gastroenterology"},{"key":"2024111100501115000_69.6.1127.29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.29581","article-title":"Cell death markers in patients with cirrhosis and acute decompensation","volume":"67","author":"Macdonald","year":"2018","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"2024111100501115000_69.6.1127.31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"2024111100501115000_69.6.1127.32","first-page":"177A","article-title":"Necroptosis: a novel target for the prevention of progression of acute on chronic liver failure","volume":"68","author":"Kondo","year":"2018","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.33","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.34","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"2024111100501115000_69.6.1127.35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with e","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase Mertk","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology"},{"key":"2024111100501115000_69.6.1127.38","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/gutjnl-2017-314184","article-title":"CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure","volume":"67","author":"Bernsmeier","year":"2018","journal-title":"Gut"},{"key":"2024111100501115000_69.6.1127.39","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1136\/gutjnl-2018-316888","article-title":"Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity","volume":"68","author":"Korf","year":"2019","journal-title":"Gut"},{"key":"2024111100501115000_69.6.1127.40","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.21737","article-title":"Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome","volume":"46","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.41","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med"},{"key":"2024111100501115000_69.6.1127.42","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3932","article-title":"An evolutionary perspective on immunometabolism","volume":"363","author":"Wang","year":"2019","journal-title":"Science"},{"key":"2024111100501115000_69.6.1127.43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.1840060217","article-title":"Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis","volume":"6","author":"Rajkovic","year":"1986","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.44","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/hep.22474","article-title":"Ammonia impairs neutrophil phagocytic function in liver disease","volume":"48","author":"Shawcross","year":"2008","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.45","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2010.11.034","article-title":"Evidence of neutrophil functional defect despite inflammation in stable cirrhosis","volume":"55","author":"Tritto","year":"2011","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.46","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"2024111100501115000_69.6.1127.47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International club of ascites (ICa) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.48","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/hep.29612","article-title":"Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality","volume":"67","author":"Jansen","year":"2018","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/apt.15365","article-title":"Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90-day mortality","volume":"50","author":"Jansen","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2024111100501115000_69.6.1127.50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2019.01.050","article-title":"Energetic trade-offs and hypometabolic states promote disease tolerance","volume":"177","author":"Ganeshan","year":"2019","journal-title":"Cell"},{"key":"2024111100501115000_69.6.1127.51","doi-asserted-by":"crossref","unstructured":"Moreau R , Cl\u00e0ria J , Aguilar F , et al . Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J Hepatol 2019. doi:doi:10.1016\/j.jhep.2019.11.009. [Epub ahead of print: 25 Nov 2019].","DOI":"10.1016\/j.jhep.2019.11.009"},{"key":"2024111100501115000_69.6.1127.52","unstructured":"Peters T . All about albumin: biochemistry, genetics and medical applications. San Diego, CA: Academic Press Limited, 1996."},{"key":"2024111100501115000_69.6.1127.53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1006\/jmbi.2000.4158","article-title":"Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin","volume":"303","author":"Bhattacharya","year":"2000","journal-title":"J Mol Biol"},{"key":"2024111100501115000_69.6.1127.54","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1073\/pnas.74.4.1358","article-title":"Rat liver preproalbumin: in vitro synthesis and partial amino acid sequence","volume":"74","author":"Strauss","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024111100501115000_69.6.1127.55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-3233(08)60065-0","article-title":"Serum albumin","volume":"37","author":"Peters","year":"1985","journal-title":"Advances in Advances in Protein Chemistry"},{"key":"2024111100501115000_69.6.1127.56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J Exp Med"},{"key":"2024111100501115000_69.6.1127.57","doi-asserted-by":"crossref","first-page":"E2862","DOI":"10.1073\/pnas.1618291114","article-title":"Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury","volume":"114","author":"Pyzik","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024111100501115000_69.6.1127.58","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.59","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1016\/j.bbagen.2013.04.012","article-title":"Novel insights into the pleiotropic effects of human serum albumin in health and disease","volume":"1830","author":"Ha","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2024111100501115000_69.6.1127.60","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0022-2275(20)35729-1","article-title":"Comparative binding of bile acids to serum lipoproteins and albumin","volume":"34","author":"Ceryak","year":"1993","journal-title":"J Lipid Res"},{"key":"2024111100501115000_69.6.1127.61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0016-5085(84)80022-0","article-title":"Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis","volume":"86","author":"Ohkubo","year":"1984","journal-title":"Gastroenterology"},{"key":"2024111100501115000_69.6.1127.62","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1172\/JCI115149","article-title":"Fatty acid distribution in systems modeling the normal and diabetic human circulation. A 13C nuclear magnetic resonance study","volume":"87","author":"Cistola","year":"1991","journal-title":"J Clin Invest"},{"key":"2024111100501115000_69.6.1127.63","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/hep.30363","article-title":"Orchestration of tryptophan-kynurenine pathway, acute decompensation, and acute-on-chronic liver failure in cirrhosis","volume":"69","author":"Cl\u00e0ria","year":"2019","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.64","first-page":"753","article-title":"Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis","volume":"22","author":"Luca","year":"1995","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.65","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","journal-title":"Gastroenterology"},{"key":"2024111100501115000_69.6.1127.66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"2024111100501115000_69.6.1127.67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.68","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.70","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2014.10.031","article-title":"Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure","volume":"62","author":"Garcia-Martinez","year":"2015","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0888-6296(88)80004-8","article-title":"Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume expanders","volume":"2","author":"Quon","year":"1988","journal-title":"J Cardiothorac Anesth"},{"key":"2024111100501115000_69.6.1127.72","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.73","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","article-title":"Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis","volume":"60","author":"Domenicali","year":"2014","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.74","doi-asserted-by":"crossref","DOI":"10.1038\/srep35987","article-title":"Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule","volume":"6","author":"Baldassarre","year":"2016","journal-title":"Sci Rep"},{"key":"2024111100501115000_69.6.1127.75","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/hep.30135","article-title":"Oxidized albumin triggers a cytokine storm in leukocytes through p38 mitogen-activated protein kinase: role in systemic inflammation in decompensated cirrhosis","volume":"68","author":"Alcaraz-Quiles","year":"2018","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.76","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.77","doi-asserted-by":"crossref","DOI":"10.1016\/S0618-8278(19)30095-7","article-title":"PS-083-Serum albumin concentration as guide for long-term albumin treatment in patients with cirrhosis and uncomplicated ascites: lessons from the answer study","volume":"70","author":"Caraceni","year":"2019","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.78","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"Gentilini","year":"1999","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.79","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-Term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"2024111100501115000_69.6.1127.80","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-Term albumin administration in decompensated cirrhosis (answer): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"2024111100501115000_69.6.1127.81","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.13968","article-title":"Long-Term administration of human albumin improves survival in patients with cirrhosis and refractory ascites","volume":"39","author":"Di Pascoli","year":"2019","journal-title":"Liver Int"},{"key":"2024111100501115000_69.6.1127.83","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.84","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.85","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.86","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2013.08.001","article-title":"Effective albumin concentration and cirrhosis mortality: from concept to reality","volume":"59","author":"Jalan","year":"2013","journal-title":"J Hepatol"},{"key":"2024111100501115000_69.6.1127.87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(10)74011-8","article-title":"Redox state of human serum albumin in terms of cysteine-34 in health and disease","volume":"474","author":"Oettl","year":"2010","journal-title":"Methods Enzymol"},{"key":"2024111100501115000_69.6.1127.88","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023754","article-title":"Attire: albumin to prevenT infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial","volume":"8","author":"China","year":"2018","journal-title":"BMJ Open"},{"key":"2024111100501115000_69.6.1127.89","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"2024111100501115000_69.6.1127.90","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the relief trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.91","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"Hassanein","year":"2007","journal-title":"Hepatology"},{"key":"2024111100501115000_69.6.1127.92","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2015.04.020","article-title":"Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: results of a pivotal pre-clinical study","volume":"63","author":"Lee","year":"2015","journal-title":"J Hepatol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2019-318843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T03:53:07Z","timestamp":1731297187000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2019-318843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":92,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,5,7]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/gutjnl-2019-318843"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2019-318843","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737450288.793584788","asserted-by":"object"}]},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]}}}